Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
doi: 10.1038/cddis.2013.139 208 ZhengJXieYRenLQiLWuLPanXet al
On the other hand, it is becoming clear that obesity and diabetes themselves affect the pathogenesis, progression, and prognosis of heart failure with preserved ejection fraction (HFpEF)
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor Tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
The research found no negative effects on carbohydrate metabolism across all dose ranges studied
US$ 27.57
US$ 27.25
US$ 27.91
US$ 29.34
